ADELIS provides the market with a unique offer of detectors covering a large range of wavelengths from UV to visible to quantify naturally fluorescent compounds as well as derivatives. The company can assist the analysts in the development of separation methods as well as derivatization methods.

The detectors are employed in a broad range of applications including the analysis of Amino acids, Homocystein and Cystein, Peptides, Biogenic amines, Proteins/Oligoproteins, Sugars, Alcohols/Thiols, Organic acids, Pesticides and Aromatic Pollutants.

Moreover, ADELIS is currently developing a new range of products based on an innovative, patented concentration, separation and purification technique (μLAS) invented by the French National Research Agency (CNRS). The μLAS platform is an enabling technology, which paves the way to profile from low (100 bp) to high (> 200 kbp) molecular weight DNA for a large range of market applications. In particular, the technology is the unique technology able to profile circulating cell-free DNA in blood samples. ADELIS offers cfDNA analysis services as service delivery or in partnership extending its large analytical methods portfolio for its customers. Its sister company ID-Solutions offers a complete workflow for oncology diagnostic on circulating DNA from liquid biopsy and tumour DNA from solid biopsy.

ADELIS SAS Downloads

AdELIS - BIABooster System - Brochure